O	O	O	0	8	Evidence	Evidence	B-NP	NN	O	0	ROOT	O
O	O	O	9	12	for	for	B-PP	IN	O	1	NMOD	O
O	O	O	13	20	lowered	lowered	B-NP	JJ	O	4	NMOD	O
O	O	O	21	30	induction	induction	I-NP	NN	O	2	PMOD	O
O	O	O	31	33	of	of	B-PP	IN	O	4	NMOD	O
T5	B-Entity	B-Entity	34	41	nuclear	nuclear	B-NP	JJ	B-protein	9	NMOD	B-protein
T5	I-Entity	I-Entity	42	48	factor	factor	I-NP	NN	I-protein	9	NMOD	I-protein
T5	I-Entity	I-Entity	49	54	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T5	I-Entity	I-Entity	55	56	B	B	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	57	59	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	60	69	activated	activate	B-NP	VBN	B-cell_type	14	NMOD	B-cell_type
O	O	O	70	75	human	human	I-NP	JJ	I-cell_type	14	NMOD	I-cell_type
O	O	O	76	77	T	T	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	78	89	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	O	90	96	during	during	B-PP	IN	O	4	NMOD	O
O	O	O	97	102	aging	aging	B-NP	NN	O	15	PMOD	O
O	O	O	102	103	.	.	O	.	O	1	P	O

O	O	O	105	118	Transcription	Transcription	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	119	125	factor	factor	I-NP	NN	I-protein	5	NMOD	I-protein
T6	B-Entity	B-Entity	126	128	NF	NF	I-NP	NN	B-protein	5	NMOD	B-protein
T6	I-Entity	I-Entity	129	134	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T6	I-Entity	I-Entity	135	136	B	B	I-NP	NN	I-protein	12	SUB	I-protein
O	O	O	137	138	(	(	O	(	O	11	DEP	O
T7	B-Entity	B-Entity	138	145	nuclear	nuclear	B-NP	JJ	B-protein	10	NMOD	B-protein
T7	I-Entity	I-Entity	146	152	factor	factor	I-NP	NN	I-protein	10	NMOD	I-protein
T7	I-Entity	I-Entity	153	158	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T7	I-Entity	I-Entity	159	160	B	B	I-NP	NN	I-protein	11	DEP	I-protein
O	O	O	160	161	)	)	O	)	O	5	NMOD	O
O	O	O	162	164	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	165	172	induced	induce	I-VP	VBN	O	12	VC	O
O	O	O	173	175	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	176	177	T	T	B-NP	NN	B-cell_type	16	NMOD	B-cell_type
O	O	O	178	189	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	O	190	194	from	from	B-PP	IN	O	16	NMOD	O
O	O	O	195	200	young	young	B-NP	JJ	O	19	NMOD	O
O	O	O	201	212	individuals	individual	I-NP	NNS	O	17	PMOD	O
O	O	O	213	222	following	follow	B-PP	VBG	O	13	VMOD	O
O	O	O	223	233	activation	activation	B-NP	NN	O	20	PMOD	O
O	O	O	234	238	with	with	B-PP	IN	O	21	NMOD	O
O	O	O	239	240	a	a	B-NP	DT	O	24	NMOD	O
O	O	O	241	248	variety	variety	I-NP	NN	O	22	PMOD	O
O	O	O	249	251	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	252	259	stimuli	stimulus	B-NP	NNS	O	25	PMOD	O
O	O	O	260	269	including	include	B-PP	VBG	O	26	NMOD	O
O	O	O	270	274	anti	anti	B-NP	AFX	O	34	NMOD	O
O	O	O	274	275	-	-	I-NP	HYPH	O	34	NMOD	O
T8	B-Entity	B-Entity	275	278	CD3	CD3	B-NP	NN	B-protein	34	NMOD	B-protein
O	O	O	278	279	,	,	O	,	O	34	P	O
O	O	O	280	287	phorbol	phorbol	B-NP	NN	O	34	NMOD	O
O	O	O	288	297	myristate	myristate	I-NP	NN	O	34	NMOD	O
O	O	O	298	305	acetate	acetate	I-NP	NN	O	27	PMOD	O
O	O	O	306	307	(	(	O	(	O	37	DEP	O
O	O	O	307	310	PMA	PMA	B-NP	NN	O	37	DEP	O
O	O	O	310	311	)	)	O	)	O	34	NMOD	O
O	O	O	311	312	,	,	O	,	O	44	P	O
O	O	O	313	316	and	and	O	CC	O	44	NMOD	O
T1	B-Protein	B-Protein	317	322	tumor	tumor	B-NP	NN	B-protein	44	NMOD	B-protein
T1	I-Protein	I-Protein	323	331	necrosis	necrosis	I-NP	NN	I-protein	44	NMOD	I-protein
T1	I-Protein	I-Protein	332	338	factor	factor	I-NP	NN	I-protein	44	NMOD	I-protein
T1	I-Protein	I-Protein	338	339	-	-	O	HYPH	I-protein	44	P	I-protein
T1	I-Protein	I-Protein	339	344	alpha	alpha	B-NP	SYM	I-protein	12	PRD	I-protein
O	O	O	345	346	(	(	O	(	O	49	DEP	O
T2	B-Protein	B-Protein	346	349	TNF	TNF	B-NP	NN	B-protein	48	NMOD	B-protein
T2	I-Protein	I-Protein	349	350	-	-	O	HYPH	I-protein	48	P	I-protein
T2	I-Protein	I-Protein	350	355	alpha	alpha	B-NP	SYM	I-protein	49	DEP	I-protein
O	O	O	355	356	)	)	O	)	O	44	NMOD	O
O	O	O	356	357	.	.	O	.	O	12	P	O

O	O	O	358	360	In	In	B-PP	IN	O	10	VMOD	O
O	O	O	361	369	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	369	370	,	,	O	,	O	10	P	O
O	O	O	371	380	activated	activate	B-NP	VBN	O	6	NMOD	O
O	O	O	381	382	T	T	I-NP	NN	B-cell_type	6	NMOD	B-cell_type
O	O	O	383	394	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	10	SUB	I-cell_type
O	O	O	395	399	from	from	B-PP	IN	O	6	NMOD	O
O	O	O	400	405	older	old	B-NP	JJR	O	9	NMOD	O
O	O	O	406	417	individuals	individual	I-NP	NNS	O	7	PMOD	O
O	O	O	418	422	show	show	B-VP	VBP	O	0	ROOT	O
O	O	O	423	424	a	a	B-NP	DT	O	13	NMOD	O
O	O	O	425	436	significant	significant	I-NP	JJ	O	13	NMOD	O
O	O	O	437	446	reduction	reduction	I-NP	NN	O	10	OBJ	O
O	O	O	447	449	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	450	453	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	454	463	induction	induction	I-NP	NN	O	14	PMOD	O
O	O	O	464	466	of	of	B-PP	IN	O	16	NMOD	O
T9	B-Entity	B-Entity	467	469	NF	NF	B-NP	NN	B-protein	20	NMOD	B-protein
T9	I-Entity	I-Entity	470	475	kappa	kappa	I-NP	NN	I-protein	20	NMOD	I-protein
T9	I-Entity	I-Entity	476	477	B	B	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	478	480	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	481	489	response	response	B-NP	NN	O	21	PMOD	O
O	O	O	490	492	to	to	B-PP	TO	O	22	NMOD	O
O	O	O	493	496	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	497	501	same	same	I-NP	JJ	O	26	NMOD	O
O	O	O	502	509	stimuli	stimulus	I-NP	NNS	O	23	PMOD	O
O	O	O	509	510	.	.	O	.	O	10	P	O

O	O	O	511	514	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	515	518	age	age	I-NP	NN	O	12	SUB	O
O	O	O	518	519	-	-	B-VP	HYPH	O	2	NMOD	O
O	O	O	519	526	related	relate	B-NP	VBN	O	5	NMOD	O
O	O	O	527	534	decline	decline	I-NP	NN	O	3	OBJ	O
O	O	O	535	537	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	538	547	induction	induction	B-NP	NN	O	6	PMOD	O
O	O	O	548	550	of	of	B-PP	IN	O	7	NMOD	O
T10	B-Entity	B-Entity	551	553	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T10	I-Entity	I-Entity	554	559	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T10	I-Entity	I-Entity	560	561	B	B	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	562	567	could	could	B-VP	MD	O	27	VMOD	O
O	O	O	568	571	not	not	I-VP	RB	O	12	VMOD	O
O	O	O	572	574	be	be	I-VP	VB	O	12	VC	O
O	O	O	575	585	attributed	attribute	I-VP	VBN	O	14	VC	O
O	O	O	586	588	to	to	B-PP	TO	O	15	VMOD	O
O	O	O	589	599	alteration	alteration	B-NP	NN	O	16	PMOD	O
O	O	O	600	602	in	in	B-PP	IN	O	17	NMOD	O
O	O	O	603	606	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	607	618	composition	composition	I-NP	NN	O	18	PMOD	O
O	O	O	619	621	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	622	630	subunits	subunit	B-NP	NNS	O	21	PMOD	O
O	O	O	630	631	,	,	O	,	O	27	P	O
T3	B-Protein	B-Protein	632	635	p50	p50	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	636	639	and	and	O	CC	O	26	NMOD	O
T4	B-Protein	B-Protein	640	643	p65	p65	B-NP	NN	B-protein	27	SUB	B-protein
O	O	O	644	648	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	649	654	found	find	I-VP	VBN	O	27	VC	O
O	O	O	655	657	to	to	I-VP	TO	O	30	VMOD	O
O	O	O	658	660	be	be	I-VP	VB	O	28	VMOD	O
O	O	O	661	664	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	665	676	predominant	predominant	I-NP	JJ	O	33	NMOD	O
O	O	O	677	685	subunits	subunit	I-NP	NNS	O	30	PRD	O
O	O	O	686	688	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	689	696	induced	induce	B-NP	VBN	O	38	NMOD	O
T11	B-Entity	B-Entity	697	699	NF	NF	I-NP	NN	B-protein	38	NMOD	B-protein
T11	I-Entity	I-Entity	700	705	kappa	kappa	I-NP	NN	I-protein	38	NMOD	I-protein
T11	I-Entity	I-Entity	706	707	B	B	I-NP	NN	I-protein	34	PMOD	I-protein
O	O	O	708	710	in	in	B-PP	IN	O	33	NMOD	O
O	O	O	711	712	T	T	B-NP	NN	B-cell_type	41	NMOD	B-cell_type
O	O	O	713	718	cells	cell	I-NP	NNS	I-cell_type	39	PMOD	I-cell_type
O	O	O	719	723	from	from	B-PP	IN	O	41	NMOD	O
O	O	O	724	729	young	young	O	JJ	O	48	NMOD	O
O	O	O	730	732	as	as	B-CONJP	RB	O	48	NMOD	O
O	O	O	733	737	well	well	I-CONJP	RB	O	44	DEP	O
O	O	O	738	740	as	as	I-CONJP	IN	O	44	DEP	O
O	O	O	741	748	elderly	elderly	B-NP	JJ	O	48	NMOD	O
O	O	O	749	755	donors	donor	I-NP	NNS	O	42	PMOD	O
O	O	O	755	756	.	.	O	.	O	27	P	O

O	O	O	757	768	Furthermore	Furthermore	B-ADVP	RB	O	9	VMOD	O
O	O	O	768	769	,	,	O	,	O	9	P	O
O	O	O	770	777	similar	similar	B-NP	JJ	O	4	NMOD	O
O	O	O	778	784	levels	level	I-NP	NNS	O	9	SUB	O
O	O	O	785	787	of	of	B-PP	IN	O	4	NMOD	O
T12	B-Entity	B-Entity	788	790	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T12	I-Entity	I-Entity	791	796	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T12	I-Entity	I-Entity	797	798	B	B	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	799	803	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	804	809	found	find	I-VP	VBN	O	9	VC	O
O	O	O	810	812	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	813	816	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	817	825	cytosols	cytosol	I-NP	NNS	O	11	PMOD	O
O	O	O	826	828	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	829	840	unactivated	unactivated	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	O	841	842	T	T	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	O	843	848	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	O	849	853	from	from	B-PP	IN	O	17	NMOD	O
O	O	O	854	858	both	both	B-NP	CC	O	23	NMOD	O
O	O	O	859	864	young	young	I-NP	JJ	O	23	NMOD	O
O	O	O	865	868	and	and	I-NP	CC	O	23	NMOD	O
O	O	O	869	876	elderly	elderly	I-NP	JJ	O	23	NMOD	O
O	O	O	877	883	donors	donor	I-NP	NNS	O	18	PMOD	O
O	O	O	884	894	suggesting	suggest	B-VP	VBG	O	9	VMOD	O
O	O	O	895	899	that	that	B-SBAR	IN	O	24	VMOD	O
T13	B-Entity	B-Entity	900	909	precursor	precursor	B-NP	NN	O	27	NMOD	O
O	O	O	910	916	levels	level	I-NP	NNS	O	32	SUB	O
T14	B-Entity	B-Entity	917	919	of	of	B-PP	IN	O	27	NMOD	O
T15	I-Entity	I-Entity	920	922	NF	NF	B-NP	NN	B-protein	31	NMOD	B-protein
T15	I-Entity	I-Entity	923	928	kappa	kappa	I-NP	NN	I-protein	31	NMOD	I-protein
T15	I-Entity	I-Entity	929	930	B	B	I-NP	NN	I-protein	28	PMOD	I-protein
O	O	O	931	937	remain	remain	B-VP	VBP	O	25	SBAR	O
O	O	O	938	947	unaltered	unaltered	B-ADJP	JJ	O	32	PRD	O
O	O	O	948	954	during	during	B-PP	IN	O	33	AMOD	O
O	O	O	955	960	aging	aging	B-NP	NN	O	34	PMOD	O
O	O	O	960	961	.	.	O	.	O	9	P	O

O	O	O	962	967	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	968	975	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	976	983	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	984	988	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	989	991	an	an	B-NP	DT	O	6	NMOD	O
O	O	O	992	995	age	age	I-NP	NN	O	24	SUB	O
O	O	O	995	996	-	-	B-VP	HYPH	O	24	P	O
O	O	O	996	1006	associated	associate	B-NP	VBN	O	9	NMOD	O
O	O	O	1007	1014	decline	decline	I-NP	NN	O	24	SUB	O
O	O	O	1015	1017	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	1018	1021	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1022	1031	induction	induction	I-NP	NN	O	10	PMOD	O
O	O	O	1032	1034	of	of	B-PP	IN	O	12	NMOD	O
T16	B-Entity	B-Entity	1035	1037	NF	NF	B-NP	NN	B-protein	16	NMOD	B-protein
T16	I-Entity	I-Entity	1038	1043	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T16	I-Entity	I-Entity	1044	1045	B	B	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	1046	1048	in	in	B-PP	IN	O	12	NMOD	O
O	O	O	1049	1058	activated	activate	B-NP	VBN	B-cell_type	20	NMOD	B-cell_type
O	O	O	1059	1060	T	T	I-NP	NN	I-cell_type	20	NMOD	I-cell_type
O	O	O	1061	1066	cells	cell	I-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	O	1067	1071	from	from	B-PP	IN	O	20	NMOD	O
O	O	O	1072	1079	elderly	elderly	B-NP	JJ	O	23	NMOD	O
O	O	O	1080	1091	individuals	individual	I-NP	NNS	O	21	PMOD	O
O	O	O	1092	1095	may	may	B-VP	MD	O	4	SBAR	O
O	O	O	1096	1098	be	be	I-VP	VB	O	24	VC	O
O	O	O	1099	1111	attributable	attributable	B-ADJP	JJ	O	25	PRD	O
O	O	O	1112	1114	to	to	B-PP	TO	O	26	AMOD	O
O	O	O	1115	1122	altered	altered	B-NP	JJ	O	29	NMOD	O
O	O	O	1123	1133	regulation	regulation	I-NP	NN	O	27	PMOD	O
O	O	O	1134	1136	of	of	B-PP	IN	O	29	NMOD	O
O	O	O	1137	1140	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	1141	1150	inhibitor	inhibitor	I-NP	NN	O	36	NMOD	O
O	O	O	1150	1151	,	,	O	,	O	36	P	O
O	O	O	1152	1153	I	I	B-NP	NN	B-protein	36	NMOD	B-protein
O	O	O	1154	1159	kappa	kappa	I-NP	NN	I-protein	36	NMOD	I-protein
O	O	O	1160	1161	B	B	I-NP	NN	I-protein	30	PMOD	I-protein
O	O	O	1161	1162	,	,	O	,	O	24	P	O
O	O	O	1163	1166	and	and	O	CC	O	24	VMOD	O
O	O	O	1167	1170	may	may	B-VP	MD	O	24	VMOD	O
O	O	O	1171	1175	play	play	I-VP	VB	O	39	VC	O
O	O	O	1176	1178	an	an	B-NP	DT	O	43	NMOD	O
O	O	O	1179	1188	important	important	I-NP	JJ	O	43	NMOD	O
O	O	O	1189	1193	role	role	I-NP	NN	O	40	OBJ	O
O	O	O	1194	1196	in	in	B-PP	IN	O	40	VMOD	O
O	O	O	1197	1203	immune	immune	B-NP	JJ	O	46	NMOD	O
O	O	O	1204	1217	dysregulation	dysregulation	I-NP	NN	O	44	PMOD	O
O	O	O	1218	1230	accompanying	accompany	B-VP	VBG	O	46	NMOD	O
O	O	O	1231	1236	aging	aging	B-NP	NN	O	47	OBJ	O
O	O	O	1236	1237	.	.	O	.	O	3	P	O
